CLINICAL_TRIALS
trial_result
· 2024-06-06
Clinical Trial Update: Trial of Oxaloacetate in ALS [Phase 1]
Summary
Phase 1 trial of oxaloacetate for amyotrophic lateral sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Omar Jawdat | Conditions: ALS | Phase 1 | Status: COMPLETED